1. 1034PPhase I study of intraperitoneal TRX-E-002-1 in subjects with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer: Three-month follow-up results of the dose escalation phase. (1st October 2019) Authors: Coward, J; Kichenadasse, G; Harnett, P; Moore, K; Barve, M; Berg, D; Garner, J; Dizon, D Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1168PPhase I/II study of CTLA-4 inhibitor AGEN1884 + PD-1 Inhibitor AGEN2034 in patients with advanced/refractory solid tumors, with expansion into 2L cervical cancer and solid tumors. (23rd October 2018) Authors: Coward, J; Lemech, C; Meniawy, T; Dupont, C D; Gonzalez, A M; Lim, M; Savitsky, D; Carini, M; Hu, S; Shebanova, O; Dow, E; Ortuzar, W; Buell, J S; Stein, R B; Youssoufian, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 94O Safety and antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors: Ovarian cancer cohort data. (15th December 2019) Authors: Gao, B; Goh, J; Markman, B; Voskoboynik, M; Gan, H K; Coward, J; Palmieri, D; So, J; Meniawy, T; Chen, C; Xiang, X; Qiu, J; Xu, Y; Yang, L; Millward, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity. Issue 1 (11th December 2014) Authors: Minchom, A R; Saksornchai, K; Bhosle, J; Gunapala, R; Puglisi, M; Lu, S K; Nimako, K; Coward, J; Yu, K C; Bordi, P; Popat, S; O'Brien, M E R Journal: BMJ open respiratory research Issue: Volume 1:Issue 1(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA12Updated results of activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601). (24th November 2019) Authors: Antill, Y; Kok, P S; Stockler, M R; Robledo, K; Yip, S; Parry, M; Smith, D; Spurdle, A; Barnes, E; Friedlander, M L; Baron-Hay, S; Shannon, C; Coward, J; Beale, P J; Goss, G; Meniawy, T; Andrews, J; Kelly, M; Mileshkin, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗